Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 6
1949 2
1951 4
1952 4
1953 1
1954 5
1955 3
1956 4
1957 3
1958 5
1959 4
1960 9
1961 11
1962 10
1963 11
1964 8
1965 6
1966 1
1967 4
1968 3
1969 5
1970 4
1971 7
1972 9
1973 8
1974 11
1975 10
1976 7
1977 8
1978 12
1979 20
1980 14
1981 21
1982 23
1983 25
1984 25
1985 37
1986 37
1987 56
1988 50
1989 68
1990 56
1991 60
1992 91
1993 87
1994 70
1995 78
1996 69
1997 61
1998 93
1999 71
2000 95
2001 73
2002 96
2003 83
2004 115
2005 118
2006 171
2007 154
2008 156
2009 131
2010 171
2011 156
2012 188
2013 178
2014 224
2015 202
2016 226
2017 228
2018 279
2019 241
2020 322
2021 390
2022 357
2023 391
2024 400
2025 399
2026 154

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,285 results

Results by year

Filters applied: . Clear all
Page 1
Graves' ophthalmopathy.
Bahn RS. Bahn RS. N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750. N Engl J Med. 2010. PMID: 20181974 Free PMC article. Review.
Graves' ophthalmopathy, also called Graves' orbitopathy, is a potentially sight-threatening ocular disease that has puzzled physicians and scientists for nearly two centuries.(-) Generally occurring in patients with hyperthyroidism or a history of hyperthyroi …
Graves' ophthalmopathy, also called Graves' orbitopathy, is a potentially sight-threatening ocular disease that has puz …
Treatment of Graves' ophthalmopathy.
González-García A, Sales-Sanz M. González-García A, et al. Med Clin (Barc). 2021 Feb 26;156(4):180-186. doi: 10.1016/j.medcli.2020.07.031. Epub 2020 Oct 14. Med Clin (Barc). 2021. PMID: 33069387 Review. English, Spanish.
Graves' ophthalmopathy is an inflammatory disease with primary involvement of the extraocular muscles and the orbit. ...The objective of this review is to update the treatment of Graves' ophthalmopathy, as well as to present alternative options in pati …
Graves' ophthalmopathy is an inflammatory disease with primary involvement of the extraocular muscles and the orbit. ...The ob …
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
Hoang TD, Stocker DJ, Chou EL, Burch HB. Hoang TD, et al. Endocrinol Metab Clin North Am. 2022 Jun;51(2):287-304. doi: 10.1016/j.ecl.2021.12.004. Epub 2022 May 11. Endocrinol Metab Clin North Am. 2022. PMID: 35662442 Free PMC article. Review.
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive managem …
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include pa …
Management of Graves' ophthalmopathy by radiotherapy: A literature review.
Beige A, Boustani J, Bouillet B, Truc G. Beige A, et al. Cancer Radiother. 2024 Jun;28(3):282-289. doi: 10.1016/j.canrad.2023.09.004. Epub 2024 Jun 20. Cancer Radiother. 2024. PMID: 38906800 Review.
Orbital radiotherapy for Graves' ophthalmopathy is an example of non-oncological radiotherapy. First introduced in the 1930s, this treatment has become widely used since the 1980s with several studies showing proof of both effectiveness and safety: a decrease of sof …
Orbital radiotherapy for Graves' ophthalmopathy is an example of non-oncological radiotherapy. First introduced in the 1930s, …
The risk factors for Graves' ophthalmopathy.
Cao J, Su Y, Chen Z, Ma C, Xiong W. Cao J, et al. Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1043-1054. doi: 10.1007/s00417-021-05456-x. Epub 2021 Nov 17. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34787691 Review.
PURPOSE: This review aimed to provide an overview of current research into the risk factors for Graves' ophthalmopathy (GO). METHODS: To find information about the risk factors for GO, the research database PubMed was searched and relevant articles were obtained to …
PURPOSE: This review aimed to provide an overview of current research into the risk factors for Graves' ophthalmopathy (GO). M …
Euthyroid Graves' ophthalmopathy.
Schattner A, Voichanski S, Pollack R, Uliel L. Schattner A, et al. QJM. 2023 Nov 24;116(11):942-943. doi: 10.1093/qjmed/hcad176. QJM. 2023. PMID: 37471697 Free article. No abstract available.
Immunotherapy for Graves' ophthalmopathy.
Salvi M. Salvi M. Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):409-14. doi: 10.1097/MED.0000000000000097. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 25105999 Review.
RECENT FINDINGS: Potential targets for immune therapy in Graves' ophthalmopathy are the antigens expressed on the target organ of inflammation, namely the receptor and the insulin growth factor -1 receptor on fibroblasts, inflammatory cytokines, and B and T cells. . …
RECENT FINDINGS: Potential targets for immune therapy in Graves' ophthalmopathy are the antigens expressed on the target organ …
Advances of IGF-1R inhibitors in Graves' ophthalmopathy.
Wang M, Liu L. Wang M, et al. Int Ophthalmol. 2024 Nov 22;44(1):435. doi: 10.1007/s10792-024-03358-5. Int Ophthalmol. 2024. PMID: 39578269 Review.
Graves' ophthalmopathy is the most common extra-thyroidal organ manifestation of Graves' disease. ...IGF-1R is an important component of the signaling pathway in Graves' ophthalmopathy, and downstream signaling of IGF-1 and IGF-1R plays a role i …
Graves' ophthalmopathy is the most common extra-thyroidal organ manifestation of Graves' disease. ...IGF-1R is an impor …
Practical Guidelines Management of Graves Ophthalmopathy.
Subekti I, Soewondo P, Soebardi S, Darmowidjojo B, Harbuwono DS, Purnamasari D, Tarigan TJE, Wisnu W, Tahapary DL, Kurniawan F, Sidik M, Nusanti S, Dewiputri S, Suharko H, Suardana GG, Suroyo I, Wulani V, Siswoyo AD, Gondhowiardjo S, Kodrat H. Subekti I, et al. Acta Med Indones. 2019 Oct;51(4):364-371. Acta Med Indones. 2019. PMID: 32041923 Free article.
Graves' ophthalmopathy is the most common extra-thyroid manifestation in patients with Graves' disease, based on inflammatory and autoimmune conditions in orbital tissue. This practical guideline was formed by a multidiciplinary team, and is intended to provi …
Graves' ophthalmopathy is the most common extra-thyroid manifestation in patients with Graves' disease, based on inflam …
Management of Graves' ophthalmopathy.
Wiersinga WM. Wiersinga WM. Nat Clin Pract Endocrinol Metab. 2007 May;3(5):396-404. doi: 10.1038/ncpendmet0497. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17452966 Review.
A wait-and-see policy is recommended in mild Graves' ophthalmopathy because the natural history of this condition reveals a tendency to resolve spontaneously. Active, moderately severe Graves' ophthalmopathy qualifies for immunosuppression: intravenous …
A wait-and-see policy is recommended in mild Graves' ophthalmopathy because the natural history of this condition reveals a te …
6,285 results